<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN""http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html><head><title>Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced ... - Google Patents</title><script>(function(){(function(){function e(a){this.t={};this.tick=function(a,c,b){var d=void 0!=b?b:(new Date).getTime();this.t[a]=[d,c];if(void 0==b)try{window.console.timeStamp("CSI/"+a)}catch(e){}};this.tick("start",null,a)}var a;window.performance&&(a=window.performance.timing);var f=a?new e(a.responseStart):new e;window.jstiming={Timer:e,load:f};if(a){var c=a.navigationStart,d=a.responseStart;0<c&&d>=c&&(window.jstiming.srt=d-c)}if(a){var b=window.jstiming.load;0<c&&d>=c&&(b.tick("_wtsrt",void 0,c),b.tick("wtsrt_",
"_wtsrt",d),b.tick("tbsd_","wtsrt_"))}try{a=null,window.chrome&&window.chrome.csi&&(a=Math.floor(window.chrome.csi().pageT),b&&0<c&&(b.tick("_tbnd",void 0,window.chrome.csi().startE),b.tick("tbnd_","_tbnd",c))),null==a&&window.gtbExternal&&(a=window.gtbExternal.pageT()),null==a&&window.external&&(a=window.external.pageT,b&&0<c&&(b.tick("_tbnd",void 0,window.external.startE),b.tick("tbnd_","_tbnd",c))),a&&(window.jstiming.pt=a)}catch(g){}})();})();
</script><link rel="stylesheet" href="/patents/css/_8a2b04e7bf975d5171d8e4c0b6365c7a/kl_intl_patents_bundle.css" type="text/css" /><script src="/books/javascript/atb_8a2b04e7bf975d5171d8e4c0b6365c7a__en.js"></script><script>function googleTranslateElementInit() {new google.translate.TranslateElement({pageLanguage: "en",gaTrack: true,gaId: "UA-27188110-1",multilanguagePage: true});}</script><script src="//translate.google.com/translate_a/element.js?cb=googleTranslateElementInit"></script><meta name="DC.type" content="Patent"><meta name="DC.title" content="Methods and preparations of extracts of Uncaria species with reduced alkaloid content"><meta name="DC.contributor" content="Paul J. Bobrowski" scheme="inventor"><meta name="DC.contributor" content="Rainforest Nutritionals, Inc." scheme="assignee"><meta name="DC.date" content="2003-9-30" scheme="dateSubmitted"><meta name="DC.description" content="The method herein describes a process for the preparation and extraction of components from plants of the family Rubiaceae indigenous to South America, also known as Cat&#39;s Claw or Uña de gato. Cat&#39;s claw is an ethnomedicine that contains a variety of constituents, some of which have opposing actions. Oxindole and pentacyclic alkaloids have been proposed to be constituents that stimulate immune function, whereas polar constituents act to suppress immune response. An extract that was devoid of the aforementioned alkaloids would avoid opposing actions that may negate effectiveness or limit therapeutic outcome."><meta name="DC.date" content="2004-9-28" scheme="issued"><meta name="DC.relation" content="US:4844901" scheme="references"><meta name="DC.relation" content="US:4940725" scheme="references"><meta name="DC.relation" content="US:5302611" scheme="references"><meta name="DC.relation" content="US:5723625" scheme="references"><meta name="DC.relation" content="US:6039949" scheme="references"><meta name="DC.relation" content="US:6238675" scheme="references"><meta name="DC.relation" content="US:6264994" scheme="references"><meta name="DC.relation" content="US:6361805" scheme="references"><meta name="citation_reference" content="G Konwalinka, Capillary electrophoretic analysis of oxidole alkaloids from Uncaria tomentosa, J of Chromatography, 609 (1992) pp 375-380, U.S."><meta name="citation_reference" content="G. Laus et al., Separation of Stereoisomeric oxidole alkaloids from Uncaria tomentosa by high performance liquid chromatography, J Chromatography, A, 662 (1994) U.S."><meta name="citation_reference" content="H Stuppner et al, HPLC Analysis of the Main Oxidole Alkaloids from Uncaria tomentosa, Chromatography, V 34, No 11/12, Dec. 1992, U.S."><meta name="citation_reference" content="J Piscoya et al., Efficacy and safety of freeze-dried cat&#39;s claw in osteorarthritis of the knee: mechanisms . . . , Inflamm.res.50(2001) 442-448, U.S."><meta name="citation_reference" content="K Keplinger et al, Uncaria tomentosa (Willd.) DC.-Ethnomedicinal use and new pharmacological, toxicological and botanical results, J Ethnopharmacology 64 (1999) 23-34 U.S."><meta name="citation_reference" content="M Sandoval et al., Cat&#39;s Claw Inhibits TNalpha Prod. and Scavenges Free Radicals: Role in Cytoprotection, Free Radical Biology &amp; Med, vol. 29 No. 1 pp 71-78,2000, U.S."><meta name="citation_reference" content="M Sandoval-Chacon, Antiinflammatory actions of cat&#39;s claw: the role of NF-kappaB, Aliment Pharmacol Ther 1998;12;1279-1289 U.S."><meta name="citation_reference" content="M Sandoval-Chacon, Antiinflammatory actions of cat&#39;s claw: the role of NF-κB, Aliment Pharmacol Ther 1998;12;1279-1289 U.S."><meta name="citation_reference" content="M. Sandoval et al., Anti-inflammatory and antioxidant activities of cat&#39;s claw (Uncaria tomentosa and Uncaria guianensis) are indept . . . , Phytomedicine 9:325-337, 2002, U.S."><meta name="citation_reference" content="Mark JS Miller et al., Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis, BMC Comp and Alternative Med Dec. 2001, I:II, U.S."><meta name="citation_reference" content="Medical Botany, Lewis et al., published 1977 by John Wiley &amp; Sons (NY), pp 277-279 and 509.*"><meta name="citation_reference" content="R Aquino et al, New quinovic acid glycosides from Uncaria Tomentosa, J Natural Prod, vol. 51, No. 2, pp 257-261, Mar.-Apr. 1998, U.S."><meta name="citation_reference" content="S Lamm, Persistant response to pneumococcal vaccine in individuals supplemented with a novel water soluable extract of Uncaria tomentosa, C-MED-100(R) Phytomedicine, vol. 8(4) pp. 267-274 U.S., no date provided."><meta name="citation_reference" content="S Lamm, Persistant response to pneumococcal vaccine in individuals supplemented with a novel water soluable extract of Uncaria tomentosa, C-MED-100® Phytomedicine, vol. 8(4) pp. 267-274 U.S., no date provided."><meta name="citation_reference" content="Y Sheng et al, Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa, J Ethnopharmacology 69 (2000) 115-126 US."><meta name="citation_reference" content="Y Sheng et al, Induction of Apoptosis and Inhibition of Proliferation of Human Tumor Cells Treated with Extracts of Uncaria Tomentosa, Anticancer Research 18:3363-3368 (1998)."><meta name="citation_patent_number" content="US:6797286"><meta name="citation_patent_application_number" content="US:10/674,986"><link rel="canonical" href="http://www.google.com/patents/US6797286"/><meta property="og:url" content="http://www.google.com/patents/US6797286"/><meta name="title" content="Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced alkaloid content"/><meta name="description" content="The method herein describes a process for the preparation and extraction of components from plants of the family Rubiaceae indigenous to South America, also known as Cat&#39;s Claw or Uña de gato. Cat&#39;s claw is an ethnomedicine that contains a variety of constituents, some of which have opposing actions. Oxindole and pentacyclic alkaloids have been proposed to be constituents that stimulate immune function, whereas polar constituents act to suppress immune response. An extract that was devoid of the aforementioned alkaloids would avoid opposing actions that may negate effectiveness or limit therapeutic outcome."/><meta property="og:title" content="Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced alkaloid content"/><meta property="og:type" content="book"/><meta property="og:site_name" content="Google Books"/><meta property="og:image" content="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><link rel="image_src" href="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"/><script>(function(){try{var aa=function(a,b,c,d){d=d||{};d._sn=["cfg",b,c].join(".");window.gbar.logger.ml(a,d)};var g=window.gbar=window.gbar||{},l=window.gbar.i=window.gbar.i||{},m={},n;function _tvn(a,b){var c=parseInt(a,10);return isNaN(c)?b:c}function _tvf(a,b){var c=parseFloat(a);return isNaN(c)?b:c}function _tvv(a){return!!a}function p(a,b,c){(c||g)[a]=b}g.bv={n:_tvn("2",0),r:"",f:".67.",e:"0",m:_tvn("0",1)};
function q(a,b,c){var d="on"+b;if(a.addEventListener)a.addEventListener(b,c,!1);else if(a.attachEvent)a.attachEvent(d,c);else{var f=a[d];a[d]=function(){var a=f.apply(this,arguments),b=c.apply(this,arguments);return void 0==a?b:void 0==b?a:b&&a}}}var s=function(a){return function(){return g.bv.m==a}},ba=s(1),ca=s(2);p("sb",ba);p("kn",ca);l.a=_tvv;l.b=_tvf;l.c=_tvn;l.i=aa;var da=window.gbar.i.i;var t,u,v,w;function ea(a){v=a}function fa(a){var b;if(b=v&&window.encodeURIComponent)b=a.href,b=!b.match(/^http[s]?:\/\/accounts\.google\.[^/]*\/ClearSID/i)&&!b.match(/^http[s]?:\/\/[^/]*\/accounts\/ClearSID/i);if(b=b&&encodeURIComponent(v()))a.href=a.href.replace(/([?&]continue=)[^&]*/,"$1"+b)}function ga(a){window.gApplication&&(a.href=window.gApplication.getTabUrl(a.href))}
function ha(a){var b=document.forms[0].q,c=window.encodeURIComponent&&b&&b.value,b=b&&b.placeholder;c&&c!=b&&(a.href=a.href.replace(/([?&])q=[^&]*|$/,function(a,b){return(b||"&")+"q="+encodeURIComponent(c)}))}n=l.a("")?ga:ha;
function x(a,b,c,d,f,e){var h=document.getElementById(a);if(h){var k=h.style;k.left=d?"auto":b+"px";k.right=d?b+"px":"auto";k.top=c+"px";k.visibility=u?"hidden":"visible";f&&e?(k.width=f+"px",k.height=e+"px"):(x(t,b,c,d,h.offsetWidth,h.offsetHeight),u=u?"":a)}}
var y=[],ia=function(a,b){y.push(b)},ja=function(a){a=a||window.event;var b=a.target||a.srcElement;a.cancelBubble=!0;null==t&&(a=document.createElement(Array.every||window.createPopup?"iframe":"div"),a.frameBorder="0",t=a.id="gbs",a.src="javascript:''",b.parentNode.appendChild(a),q(document,"click",z));var c=b,b=0;"gb3"!=c.className&&(c=c.parentNode);a=c.getAttribute("aria-owns")||"gbi";var d=c.offsetWidth,f=20<c.offsetTop?46:24;document.getElementById("tphdr")&&(f-=3);var e=!1;do b+=c.offsetLeft||
0;while(c=c.offsetParent);var c=(document.documentElement.clientWidth||document.body.clientWidth)-b-d,h,d=document.body,k=document.defaultView;k&&k.getComputedStyle?(d=k.getComputedStyle(d,""))&&(h=d.direction):h=d.currentStyle?d.currentStyle.direction:d.style.direction;h="rtl"==h;if("gbi"==a){for(d=0;k=y[d++];)k();A(null,window.navExtra);h&&(b=c,e=!0)}else h||(b=c,e=!0);u!=a&&z();x(a,b,f,e)},z=function(){u&&x(u,0,0)},A=function(a,b){var c,d=document.getElementById("gbi"),f=a;f||(f=d.firstChild);
for(;b&&(c=b.pop());){var e=d,h=c,k=f;w||(w="gb2");e.insertBefore(h,k).className=w}},ka=function(a,b,c){if((b=document.getElementById(b))&&a){a.className="gb4";var d=document.createElement("span");d.appendChild(a);d.appendChild(document.createTextNode(" | "));d.id=c;b.appendChild(d)}},la=function(){return document.getElementById("gb_70")},ma=function(){return!!u};p("qs",n);p("setContinueCb",ea);p("pc",fa);p("tg",ja);p("close",z);p("addLink",ka);p("almm",A);p("si",la);p("adh",ia);p("op",ma);var B=function(){},C=function(){},F=function(a){var b=new Image,c=D;b.onerror=b.onload=b.onabort=function(){try{delete E[c]}catch(a){}};E[c]=b;b.src=a;D=c+1},E=[],D=0;p("logger",{il:C,ml:B,log:F});var G=window.gbar.logger;var H={},na={},I=[],oa=l.b("0.1",.1),pa=l.a("1",!0),qa=function(a,b){I.push([a,b])},ra=function(a,b){H[a]=b},sa=function(a){return a in H},J={},K=function(a,b){J[a]||(J[a]=[]);J[a].push(b)},ta=function(a){K("m",a)},L=function(a,b){var c=document.createElement("script");c.src=a;c.async=pa;Math.random()<oa&&(c.onerror=function(){c.onerror=null;B(Error("Bundle load failed: name="+(b||"UNK")+" url="+a))});(document.getElementById("xjsc")||document.getElementsByTagName("body")[0]||
document.getElementsByTagName("head")[0]).appendChild(c)},N=function(a){for(var b=0,c;(c=I[b])&&c[0]!=a;++b);!c||c[1].l||c[1].s||(c[1].s=!0,M(2,a),c[1].url&&L(c[1].url,a),c[1].libs&&m.d&&m.d(c[1].libs))},O=function(a){K("gc",a)},P=null,ua=function(a){P=a},M=function(a,b,c){if(P){a={t:a,b:b};if(c)for(var d in c)a[d]=c[d];try{P(a)}catch(f){}}};p("mdc",H);p("mdi",na);p("bnc",I);p("qGC",O);p("qm",ta);p("qd",J);p("lb",N);p("mcf",ra);p("bcf",qa);p("aq",K);p("mdd","");p("has",sa);
p("trh",ua);p("tev",M);var Q=l.b("0.1",.001),R=0;
function _mlToken(a,b){try{if(1>R){R++;var c,d=a,f=b||{},e=encodeURIComponent,h=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&jexpid=",e("17483"),"&srcpg=",e("prop=22"),"&jsr=",Math.round(1/Q),"&ogev=",e("gZbtU-PUKPOwsQTAi4A4"),"&ogf=",g.bv.f,"&ogrp=",e("1"),"&ogv=",e("1407723702.0"),"&oggv="+e("es_plusone_gc_20140723.0_p0"),"&ogd=",e("com"),"&ogc=",e("ITA"),"&ogl=",e("en")];f._sn&&(f._sn="og."+
f._sn);for(var k in f)h.push("&"),h.push(e(k)),h.push("="),h.push(e(f[k]));h.push("&emsg=");h.push(e(d.name+":"+d.message));var r=h.join("");S(r)&&(r=r.substr(0,2E3));c=r;var Aa=window.gbar.logger._aem(a,c);F(Aa)}}catch(Na){}}var S=function(a){return 2E3<=a.length},va=function(a,b){return b};function T(a){B=a;p("_itl",S,G);p("_aem",va,G);p("ml",B,G);a={};H.er=a}l.a("")?T(function(a){throw a;}):l.a("1")&&Math.random()<Q&&T(_mlToken);I.push(["m",{url:"//ssl.gstatic.com/gb/js/scm_7385cc5883250b43a39405734c1bea59.js"}]);g.mcf("c",{});g.sg={c:""};if(l.a("1")){var wa=l.a("");I.push(["gc",{auto:wa,url:"//ssl.gstatic.com/gb/js/abc/gci_91f30755d6a6b787dcc2a4062e6e9824.js",libs:"googleapis.client:plusone:gapi.iframes"}]);var xa={version:"gci_91f30755d6a6b787dcc2a4062e6e9824.js",index:"",lang:"en"};H.gc=xa;var U=function(a){window.googleapis&&window.iframes?a&&a():(a&&O(a),N("gc"))};p("lGC",U);l.a("1")&&p("lPWF",U)};window.__PVT="";if(l.a("1")&&l.a("1")){var V=function(a){U(function(){K("pw",a);N("pw")})};p("lPW",V);I.push(["pw",{url:"//ssl.gstatic.com/gb/js/abc/pwm_45f73e4df07a0e388b0fa1f3d30e7280.js"}]);var W=[],ya=function(a){W[0]=a},za=function(a,b){var c=b||{};c._sn="pw";B(a,c)},Ba={signed:W,elog:za,base:"https://plusone.google.com/u/0",loadTime:(new Date).getTime()};H.pw=Ba;var X=function(a,b){for(var c=b.split("."),d=function(){var b=arguments;a(function(){for(var a=g,d=0,e=c.length-1;d<e;++d)a=a[c[d]];a[c[d]].apply(a,b)})},f=g,e=0,h=c.length-1;e<h;++e)f=
f[c[e]]=f[c[e]]||{};return f[c[e]]=d};X(V,"pw.clk");X(V,"pw.hvr");p("su",ya,g.pw)};function Ca(){function a(){for(var b;(b=e[h++])&&"m"!=b[0]&&!b[1].auto;);b&&(M(2,b[0]),b[1].url&&L(b[1].url,b[0]),b[1].libs&&m.d&&m.d(b[1].libs));h<e.length&&setTimeout(a,0)}function b(){0<f--?setTimeout(b,0):a()}var c=l.a("1"),d=l.a(""),f=3,e=I,h=0,k=window.gbarOnReady;if(k)try{k()}catch(r){da(r,"ml","or")}d?p("ldb",a):c?q(window,"load",b):b()}p("rdl",Ca);var Da={D:1,H:2,da:3,p:4,W:5,M:6,F:7,g:8,ha:9,U:10,L:11,T:12,S:13,N:14,Q:15,P:16,fa:17,w:18,O:19,ga:20,ea:21,u:22,G:23,ja:24,ka:25,ia:26,A:27,j:28,o:29,k:30,ca:31,Z:32,$:33,J:34,K:35,ba:36,aa:37,Y:38,B:39,R:40,v:41,X:42,V:43,h:48,C:49,I:500},Y=[1,2,3,4,5,6,9,10,11,13,14,28,29,30,34,35,37,38,39,40,41,42,43,48,49,500];var Z=l.b("0.001",1E-4),Ea=l.b("1",1),Fa=!1,Ga=!1;if(l.a("1")){var Ha=Math.random();Ha<=Z&&(Fa=!0);Ha<=Ea&&(Ga=!0)}var Ia=Da,$=null;function Ja(){var a=0,b=function(b,d){l.a(d)&&(a|=b)};b(1,"");b(2,"");b(4,"");b(8,"");return a}
function Ka(a,b){var c=Z,d=Fa,f;f=a;if(!$){$={};for(var e=0;e<Y.length;e++){var h=Y[e];$[h]=!0}}if(f=!!$[f])c=Ea,d=Ga;if(d){d=encodeURIComponent;g.rp?(f=g.rp(),f="-1"!=f?f:"1"):f="1";c=["//www.google.com/gen_204?atyp=i&zx=",(new Date).getTime(),"&oge=",a,"&ogex=",d("17483"),"&ogev=",d("gZbtU-PUKPOwsQTAi4A4"),"&ogf=",g.bv.f,"&ogp=",d("22"),"&ogrp=",d(f),"&ogsr=",Math.round(1/c),"&ogv=",d("1407723702.0"),"&oggv="+
d("es_plusone_gc_20140723.0_p0"),"&ogd=",d("com"),"&ogl=",d("en"),"&ogc=",d("ITA"),"&ogus=",Ja()];if(b){"ogw"in b&&(c.push("&ogw="+b.ogw),delete b.ogw);var k;f=b;e=[];for(k in f)0!=e.length&&e.push(","),e.push(La(k)),e.push("."),e.push(La(f[k]));k=e.join("");""!=k&&(c.push("&ogad="),c.push(d(k)))}F(c.join(""))}}function La(a){"number"==typeof a&&(a+="");return"string"==typeof a?a.replace(".","%2E").replace(",","%2C"):a}C=Ka;p("il",C,G);var Ma={};H.il=Ma;setTimeout(function(){C(Ia.g)},0);}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var b=window.gbar.i.i;var c=window.gbar;var f=function(d){try{var a=document.getElementById("gbom");a&&d.appendChild(a.cloneNode(!0))}catch(e){b(e,"omas","aomc")}};c.aomc=f;}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{var a=window.gbar;a.mcf("pm",{p:""});}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
(function(){try{window.gbar.rdl();}catch(e){window.gbar&&gbar.logger&&gbar.logger.ml(e,{"_sn":"cfg.init"});}})();
if (window['_OC_timingAction']) {window['_OC_timingAction']('patents_refpage');}</script><style>#gbar,#guser{font-size:13px;padding-top:1px !important;}#gbar{float:left;height:22px}#guser{padding-bottom:7px !important;text-align:right}.gbh,.gbd{border-top:1px solid #c9d7f1;font-size:1px}.gbh{height:0;position:absolute;top:24px;width:100%}#gbs,.gbm{background:#fff;left:0;position:absolute;text-align:left;visibility:hidden;z-index:1000}.gbm{border:1px solid;border-color:#c9d7f1 #36c #36c #a2bae7;z-index:1001}.gb1{margin-right:.5em}.gb1,.gb3{zoom:1}.gb2{display:block;padding:.2em .5em}.gb2,.gb3{text-decoration:none !important;border-bottom:none}a.gb1,a.gb4{text-decoration:underline !important}a.gb1,a.gb2,a.gb3,a.gb4{color:#00c !important}.gbi .gb3,.gbi .gb2,.gbi .gb4{color:#dd8e27 !important}.gbf .gb3,.gbf .gb2,.gbf .gb4{color:#900 !important}a.gb2:hover{background:#36c;color:#fff !important}#gbar .gbz0l{color:#000 !important;cursor:default;font-weight:bold;text-decoration:none !important}
#gbar { padding:.3em .6em !important;}</style></head><body  topmargin="3" marginheight="3"><div id=gbar><nobr><a onclick=gbar.qs(this);gbar.logger.il(1,{t:1}); class=gb1 id=gb_1 href="https://www.google.com/search?sa=N&tab=tw">Search</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:2}); class=gb1 id=gb_2 href="http://www.google.com/search?hl=en&tbm=isch&source=og&sa=N&tab=ti">Images</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:8}); class=gb1 id=gb_8 href="http://maps.google.com/maps?hl=en&sa=N&tab=tl">Maps</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:78}); class=gb1 id=gb_78 href="https://play.google.com/?hl=en&sa=N&tab=t8">Play</a> <a onclick=gbar.qs(this);gbar.logger.il(1,{t:36}); class=gb1 id=gb_36 href="http://www.youtube.com/results?sa=N&tab=t1">YouTube</a> <a onclick=gbar.logger.il(1,{t:5}); class=gb1 id=gb_5 href="http://news.google.com/nwshp?hl=en&tab=tn">News</a> <a onclick=gbar.logger.il(1,{t:23}); class=gb1 id=gb_23 href="https://mail.google.com/mail/?tab=tm">Gmail</a> <a onclick=gbar.logger.il(1,{t:25}); class=gb1 id=gb_25 href="https://drive.google.com/?tab=to">Drive</a> <a class=gb3 href="http://www.google.com/intl/en/options/" onclick="this.blur();gbar.tg(event);return !1" aria-haspopup=true><u>More</u> <small>&#9660;</small></a><div class=gbm id=gbi><a onclick=gbar.logger.il(1,{t:24}); class=gb2 id=gb_24 href="https://www.google.com/calendar?tab=tc">Calendar</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:51}); class=gb2 id=gb_51 href="http://translate.google.com/?hl=en&sa=N&tab=tT">Translate</a><a onclick=gbar.logger.il(1,{t:17}); class=gb2 id=gb_17 href="http://www.google.com/mobile/?hl=en&tab=tD">Mobile</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:10}); class=gb2 id=gb_10 href="http://www.google.com/search?hl=en&tbo=u&tbm=bks&source=og&sa=N&tab=tp">Books</a><a onclick=gbar.logger.il(1,{t:212}); class=gb2 id=gb_212 href="https://wallet.google.com/manage/?tab=ta">Wallet</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:6}); class=gb2 id=gb_6 href="http://www.google.com/search?hl=en&tbo=u&tbm=shop&source=og&sa=N&tab=tf">Shopping</a><a onclick=gbar.logger.il(1,{t:30}); class=gb2 id=gb_30 href="http://www.blogger.com/?tab=tj">Blogger</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:27}); class=gb2 id=gb_27 href="http://www.google.com/finance?sa=N&tab=te">Finance</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:31}); class=gb2 id=gb_31 href="https://plus.google.com/photos?sa=N&tab=tq">Photos</a><a onclick=gbar.qs(this);gbar.logger.il(1,{t:12}); class=gb2 id=gb_12 href="http://www.google.com/search?hl=en&tbo=u&tbm=vid&source=og&sa=N&tab=tv">Videos</a><div class=gb2><div class=gbd></div></div><a onclick=gbar.logger.il(1,{t:66}); href="http://www.google.com/intl/en/options/" class=gb2>Even more &raquo;</a></div></nobr></div><div id=guser width=100%><nobr><span id=gbn class=gbi></span><span id=gbf class=gbf></span><span id=gbe></span><a target=_top id=gb_70 href="https://www.google.com/accounts/Login?service=&continue=http://www.google.com/patents%3Fhl%3Den&hl=en" class=gb4>Sign in</a><div style="display: none"><div class=gbm id=gbd5 aria-owner=gbg5><div class=gbmc><ol id=gbom class=gbmcc></ol></div></div></div></nobr></div><div class=gbh style=left:0></div><div class=gbh style=right:0></div><div role="alert" style="position: absolute; left: 0; right: 0;"><a href="http://www.google.com/patents/us6797286?hl=en&amp;output=html_text" title="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."><img border="0" src="http://www.google.com/images/cleardot.gif"alt="Screen reader users: click this link for accessible mode. Accessible mode has the same essential features but works better with your reader."></a></div><div id="guser"><nobr></nobr></div><div style="clear:both;"></div><div id="gb-top-search-box" class="gb-top-search-box-small gb-reset"><table><tr><td class="logo"><a href="http://www.google.com/patents" class="logo-link"><img class="logo-img" src="/intl/en/images/logos/google_logo_41.png" alt="Go to Google Books Home" height="41"/></a></td><td><form action="http://www.google.com/search" name="f" id="vheadf" method="get"><span id="hf"></span><input type="hidden" name="tbm" value="pts"/><input type="hidden" name="tbo" value="1"/><input type="hidden" name="hl" value="en"/><table><tr><td><div class="inputs"><table><tr><td><div class="text-input"><input type="text" name="q" id="vheadq" class="text" maxlength="2048" size="31" value="" title="Search Patents" accesskey="s" autocomplete="off"/><script>window._OC_autoDir &&window._OC_autoDir('vheadq', 'tia-vheadq');</script></div></td><td><div class="submit-input"><input name="btnG" class="submit" type="submit" value=""/></div></td></tr></table></div></td><td class="col-ext-links"><div class="ext-links"><a href="http://www.google.com/advanced_patent_search">&lt;nobr&gt;Advanced Patent Search&lt;/nobr&gt;</a></div></td></tr></table></form></td></tr></table></div><div class="kd-appbar"><h2 class="kd-appname"><a href="/patents">Patents</a></h2><div class="kd-buttonbar left" id="left-toolbar-buttons"><a id="appbar-write-review-link" href=""></a><a id="appbar-view-print-sample-link" href=""></a><a id="appbar-view-ebook-sample-link" href=""></a><a id="appbar-patents-prior-art-finder-link" href="https://www.google.com/patents/related/US6797286"></a><a id="appbar-patents-discuss-this-link" href="http://www.google.com/url?id=gLRoBAABERAJ&amp;q=http://patents.stackexchange.com/redirect/google-patents%3Fpatent%3DUS6797286&amp;usg=AFQjCNFzhR3KNTqUEBU-ZtTVqh4QCimh2Q" data-is-grant="true"></a><a id="appbar-read-patent-link" href="//docs.google.com/viewer?url=patentimages.storage.googleapis.com/pdfs/US6797286.pdf"></a><a id="appbar-download-pdf-link" href="//patentimages.storage.googleapis.com/pdfs/US6797286.pdf"></a><a class="appbar-application-grant-link" data-label="Application" href="/patents/US20040068130"></a><a class="appbar-application-grant-link" data-selected="true" data-label="Grant" href="/patents/US6797286"></a></div><div class="kd-buttonbar right" id="right-toolbar-buttons"></div></div><div id="books-microdata" itemscope=""itemtype="http://schema.org/Book"itemid="http://www.google.com/patents/US6797286" style="display:none"><span itemprop="description">The method herein describes a process for the preparation and extraction of components from plants of the family Rubiaceae indigenous to South America, also known as Cat&#39;s Claw or Uña de gato. Cat&#39;s claw is an ethnomedicine that contains a variety of constituents, some of which have opposing actions....</span><span itemprop="url">http://www.google.com/patents/US6797286?utm_source=gb-gplus-share</span><span class="main-title" itemprop="name">Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced alkaloid content</span><img itemprop="image" src="http://www.google.com/patents?id=&amp;printsec=frontcover&amp;img=1&amp;zoom=1"alt="Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced alkaloid content" title="Patent US6797286 - Methods and preparations of extracts of Uncaria species with reduced alkaloid content"></div><div style="display: none"><ol id="ofe-gear-menu-contents" class="gbmcc"><li class="gbe gbmtc"><a class="gbmt goog-menuitem-content" id="" href="http://www.google.com/advanced_patent_search">Advanced Patent Search</a></li></ol></div><table id="viewport_table" cellpadding="0" style="clear:both" cellspacing="0"><tr><td id="viewport_td"><div class=vertical_module_list_row><div id=intl_patents class=about_content><div id=intl_patents_v><table class="patent-bibdata"><tr><td class="patent-bibdata-heading">Publication number</td><td class="single-patent-bibdata">US6797286 B2</td></tr><tr><td class="patent-bibdata-heading">Publication type</td><td class="single-patent-bibdata">Grant</td></tr><tr><td class="patent-bibdata-heading">Application number</td><td class="single-patent-bibdata">US 10/674,986</td></tr><tr><td class="patent-bibdata-heading">Publication date</td><td class="single-patent-bibdata">Sep 28, 2004</td></tr><tr><td class="patent-bibdata-heading">Filing date</td><td class="single-patent-bibdata">Sep 30, 2003</td></tr><tr><td class="patent-bibdata-heading">Priority date<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed."></span></td><td class="single-patent-bibdata">Oct 5, 2002</td></tr><tr><td class="patent-bibdata-heading">Fee status<span class="patent-tooltip-anchor patent-question-icon"data-tooltip-text="The fee status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status or dates listed."></span></td><td class="single-patent-bibdata">Paid</td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Also published as</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US20040068130">US20040068130</a></span></span></td></tr><tr class="patent-bibdata-list-row alternate-patent-number"><td class="patent-bibdata-heading">Publication number</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value">10674986, </span><span class="patent-bibdata-value">674986, </span><span class="patent-bibdata-value">US 6797286 B2, </span><span class="patent-bibdata-value">US 6797286B2, </span><span class="patent-bibdata-value">US-B2-6797286, </span><span class="patent-bibdata-value">US6797286 B2, </span><span class="patent-bibdata-value">US6797286B2</span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Inventors</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=ininventor:%22Paul+J.+Bobrowski%22">Paul J. Bobrowski</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Original Assignee</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="http://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Rainforest+Nutritionals,+Inc.%22">Rainforest Nutritionals, Inc.</a></span></span></td></tr><tr class="patent-bibdata-list-row "><td class="patent-bibdata-heading">Export Citation</td><td><span class="patent-bibdata-value-list"><span class="patent-bibdata-value"><a href="/patents/US6797286.bibtex">BiBTeX</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6797286.enw">EndNote</a>, </span><span class="patent-bibdata-value"><a href="/patents/US6797286.ris">RefMan</a></span></span></td></tr><tr class="patent-internal-links"><td colspan=2><span class="patent-bibdata-value"><a href="#backward-citations">Patent Citations</a> (8),</span> <span class="patent-bibdata-value"><a href="#npl-citations">Non-Patent Citations</a> (16),</span> <span class="patent-bibdata-value"><a href="#forward-citations">Referenced by</a> (2),</span> <span class="patent-bibdata-value"><a href="#classifications">Classifications</a> (7),</span> <span class="patent-bibdata-value"><a href="#legal-events">Legal Events</a> (7)</span> </td></tr><tr><td colspan=2 class="patent-bibdata-external-link-spacer-top"></td></tr><tr class="patent-bibdata-external-link-spacer-bottom"></tr><tr><td colspan=2><span class="patent-bibdata-heading">External Links:&nbsp;</span><span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://patft.uspto.gov/netacgi/nph-Parser%3FSect2%3DPTO1%26Sect2%3DHITOFF%26p%3D1%26u%3D/netahtml/PTO/search-bool.html%26r%3D1%26f%3DG%26l%3D50%26d%3DPALL%26RefSrch%3Dyes%26Query%3DPN/6797286&usg=AFQjCNHo8J0WjJ27cwAJQCjp5skj3deArw">USPTO</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://assignments.uspto.gov/assignments/q%3Fdb%3Dpat%26pat%3D6797286&usg=AFQjCNFmipfOQ96YcZ0OSJYQ1dcXmcq0yw">USPTO Assignment</a>, </span><span class="patent-bibdata-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://worldwide.espacenet.com/publicationDetails/biblio%3FCC%3DUS%26NR%3D6797286B2%26KC%3DB2%26FT%3DD&usg=AFQjCNGI4ax9rFkwpJW2A3yVGRBOaY7b6g">Espacenet</a></span></span></td></tr><tr class="patent-bibdata-group-spacer"></tr></table><div class="number-and-title"><span class="patent-title"><invention-title mxw-id="PT55321734" lang="EN" load-source="patent-office">Methods and preparations of extracts of Uncaria species with reduced alkaloid content</invention-title></span><br><span class="patent-number">US 6797286 B2</span></div><div class="patent-section patent-abstract-section"><div class="patent-section-header"><span class="patent-section-title">Abstract</span></div><div class="patent-text"><abstract mxw-id="PA50729405" lang="EN" load-source="patent-office"> <div class="abstract">The method herein describes a process for the preparation and extraction of components from plants of the family Rubiaceae indigenous to South America, also known as Cat's Claw or Uña de gato. Cat's claw is an ethnomedicine that contains a variety of constituents, some of which have opposing actions. Oxindole and pentacyclic alkaloids have been proposed to be constituents that stimulate immune function, whereas polar constituents act to suppress immune response. An extract that was devoid of the aforementioned alkaloids would avoid opposing actions that may negate effectiveness or limit therapeutic outcome.</div>
  </abstract></div></div><div class="patent-section patent-drawings-section"><div class="patent-section-header"><span class="patent-section-title">Images<span class="patent-section-count">(1)</span></span></div><div class="patent-drawings-body"><div class="patent-drawings-carousel"><div class="drawings"><div class="patent-image"><div class="patent-thumbnail"><a href="//patentimages.storage.googleapis.com/US6797286B2/US06797286-20040928-D00001.png"><img class="patent-thumbnail-image" alt="Patent Drawing"src="//patentimages.storage.googleapis.com/thumbnails/US6797286B2/US06797286-20040928-D00001.png" /></a></div><div class="patent-thumbnail-caption">&nbsp;</div></div></div></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img" alt="Previous page"src="/googlebooks/images/kennedy/page_left.png"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img" alt="Next page"src="/googlebooks/images/kennedy/page_right.png"width="21" height="21" /></div></div></div><div class="patent-post-drawings"></div><div class="patent-section patent-claims-section"><div class="patent-section-header"><span class="patent-section-title">Claims<span class="patent-section-count">(14)</span></span></div><div class="patent-text"><div mxw-id="PCLM8741870" lang="EN" load-source="patent-office" class="claims">
    <claim-statement>What is claimed is: </claim-statement> <div class="claim"> <div num="1" id="US-6797286-B2-CLM-00001" class="claim">
      <div class="claim-text">1. An extract from genus Uncaria plant material comprising polar constituents and having an oxindole alkaloid content depleted to less than about 0.3 milligrams per gram.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="2" id="US-6797286-B2-CLM-00002" class="claim">
      <div class="claim-text">2. The extract in <claim-ref idref="US-6797286-B2-CLM-00001">claim 1</claim-ref> wherein the genus Uncaria plant material has a starting oxindole alkaloids content of at least about 9 mg per gram of genus Uncaria plant material.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="3" id="US-6797286-B2-CLM-00003" class="claim">
      <div class="claim-text">3. The extract in <claim-ref idref="US-6797286-B2-CLM-00001">claim 1</claim-ref> embodied in an internally administered or topically administered pharmaceutical dosage.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="4" id="US-6797286-B2-CLM-00004" class="claim">
      <div class="claim-text">4. The pharmaceutical dosage in <claim-ref idref="US-6797286-B2-CLM-00003">claim 3</claim-ref> comprising a biologically active amount of said extract sufficient to ameliorate a condition selected from the group consisting of; NF-κB activation, oxidant burden, enhanced cytokine production and cell death.</div>
    </div>
    </div> <div class="claim-dependent"> <div num="5" id="US-6797286-B2-CLM-00005" class="claim">
      <div class="claim-text">5. The pharmaceutical dosage in <claim-ref idref="US-6797286-B2-CLM-00003">claim 3</claim-ref> comprising a biologically active amount of said extract to ameliorate a conditions selected from the group consisting of; arthritis, inflammatory bowel disease, gastritis, inflammation of the eyes, skin, liver, muscles and kidney, fibromyalgia, atherosclerosis, and Alzheimer's disease.</div>
    </div>
    </div> <div class="claim"> <div num="6" id="US-6797286-B2-CLM-00006" class="claim">
      <div class="claim-text">6. A method of extracting the lipidic components from plants of the genus Uncaria, comprising:</div>
      <div class="claim-text">decocting plant material from the genus Uncaria to resolve a decocted extract; </div>
      <div class="claim-text">filtering the solid mater from the decocted extract; </div>
      <div class="claim-text">combining the filtered decocted extract with an organic solvent; </div>
      <div class="claim-text">agitating the combination; </div>
      <div class="claim-text">separating the combination into distinct phases to resolve a genus Uncaria extract comprising polar constituents and substantially deplete of lipidic constituents; and </div>
      <div class="claim-text">evaporating the organic solvent to resolve the polar constituents. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="7" id="US-6797286-B2-CLM-00007" class="claim">
      <div class="claim-text">7. The method in <claim-ref idref="US-6797286-B2-CLM-00006">claim 6</claim-ref> further comprising,</div>
      <div class="claim-text">drying the filtered decocted extract prior to the step of combining the decoction with an organic solvent. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="8" id="US-6797286-B2-CLM-00008" class="claim">
      <div class="claim-text">8. The method of <claim-ref idref="US-6797286-B2-CLM-00006">claim 6</claim-ref> wherein, the Uncaria genus is selected from the group consisting of genera; <i>Uncaria guianensis, Uncaria homomalla, Uncaria perrottetii, Uncaria pteropoda, Uncaria rhynchopylla </i>and <i>Uncaria tomentosa. </i> </div>
    </div>
    </div> <div class="claim-dependent"> <div num="9" id="US-6797286-B2-CLM-00009" class="claim">
      <div class="claim-text">9. The method of <claim-ref idref="US-6797286-B2-CLM-00006">claim 6</claim-ref> wherein,</div>
      <div class="claim-text">the stop of filtering is achieved by a method selected from the group consisting of gravitational filtering and vacuum filtering methods. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="10" id="US-6797286-B2-CLM-00010" class="claim">
      <div class="claim-text">10. The method of <claim-ref idref="US-6797286-B2-CLM-00007">claim 7</claim-ref> wherein,</div>
      <div class="claim-text">the step of drying is achieved by a method selected from the group consisting of, air-drying, spray drying, freeze-drying and vacuum drying. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="11" id="US-6797286-B2-CLM-00011" class="claim">
      <div class="claim-text">11. The method of <claim-ref idref="US-6797286-B2-CLM-00006">claim 6</claim-ref>, wherein,</div>
      <div class="claim-text">the organic solvent is selected from the group consisting of; chloroform and methanol, and ethyl acetate. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="12" id="US-6797286-B2-CLM-00012" class="claim">
      <div class="claim-text">12. The method of <claim-ref idref="US-6797286-B2-CLM-00006">claim 6</claim-ref> wherein,</div>
      <div class="claim-text">the step of separating the combination comprises settling the combination. </div>
    </div>
    </div> <div class="claim"> <div num="13" id="US-6797286-B2-CLM-00013" class="claim">
      <div class="claim-text">13. A method of reducing the alkaloid content in an extract from plants of the genus Uncaria, comprising:</div>
      <div class="claim-text">decocting the plant material from the genus Uncaria to resolve a decocted extract; </div>
      <div class="claim-text">filtering the solid mater from the decocted extract; </div>
      <div class="claim-text">combining the filtered decocted extract with an organic solvent; </div>
      <div class="claim-text">agitating the combination; </div>
      <div class="claim-text">separating the combination to resolve a genus Uncaria extract substantially comprised of polar constituents and substantially devoid of alkaloids; and </div>
      <div class="claim-text">evaporating the organic solvent to resolve the polar constituents. </div>
    </div>
    </div> <div class="claim-dependent"> <div num="14" id="US-6797286-B2-CLM-00014" class="claim">
      <div class="claim-text">14. The method of <claim-ref idref="US-6797286-B2-CLM-00013">claim 13</claim-ref> wherein,</div>
      <div class="claim-text">the step of separating the combination comprises settling the combination. </div>
    </div>
  </div> </div></div></div><div class="patent-section patent-description-section"><div class="patent-section-header"><span class="patent-section-title">Description</span></div><div class="patent-text"><div mxw-id="PDES54306040" lang="EN" load-source="patent-office" class="description">
    <p>This application claims benefit of U.S. Provisional Application Ser. No. 60/416,730 filed on Oct. 5, 2002.</p>
    <heading>BACKGROUND OF THE INVENTION</heading> <p>1. Field of the Invention.</p>
    <p>The present invention is relevant to the field of anti-inflammatories and anti-oxidants and the manufacture of anti-inflammatories and anti-oxidants.</p>
    <p>2. Discussion of the Related Art.</p>
    <p>The indigenous inhabitants of the Amazon forests refer to plants from the Uncaria species as Uña de Gato (“Cat's claw”). These inhabitants traditionally used the Uncaria plant(s) in a raw unprocessed botanical form as a treatment for a wide array of health disorders. More specifically, ethnomedical preparations of Uncaria plant(s) were and are today consumed as decoctions or teas made from the bark of Uncaria brewed in water. Numerous researchers propose that the Uncaria chemical constituents, and particularly the alkaloids oxindole and pentacyclic, are responsible for its immune enhancing action of the plant material.</p>
    <p>Today, Cat's Claw is marketed and sold as an herbal medicine throughout the world. The primary form of these commercial preparations entails the manual manipulation of the bark, root or leaves to produce varying particulate powders. Said powders are then encapsulated for oral administration at a suggested dosage of 1-3 grams of crude material per day. It is not obvious nor has it been taught that these commercial preparations for Uncaria duplicate its historical efficacy. As of this writing, a review of the literature reveals that there has never been a single peer-reviewed scientific article demonstrating any human efficacy or health benefits derived from the oral consumption of the crude plant parts of Uncaria. Furthermore, since the solid matter from teas or decoctions is discarded (e.g. as a tea bag), it is unclear whether this solid matter would in fact cause stomach irritation, toxicity or limit the absorption of Uncaria's active ingredients.</p>
    <p>Researchers have identified inherent immunostimulating as well as immunosuppressant actions caused by the diverse chemical constituents of the Uncaria species. Researchers have determined that Uncaria's immunostimulating actions are attributable to alkaloids, pentacyclic and oxindole, that are more lipophilic than the transcriptionally active immunosuppressant components. There is prior and established art for the extraction and concentration of these lipophilic and immunostimulating alkaloids by various methods primarily utilizing alcohol rather than water as the extracting agent.</p>
    <p>Related art exists for the extraction, concentration and determination of Uncaria's lipophilic alkaloids extractions with higher alkaloid concentrations (U.S. Pat. Nos. 4844901, 4940725, 5302611, 5723625). The method uses aqueous ammonia pretreatment followed by supercritical extraction. The resultant material has been indicated for unspecific stimulation of the immune system as characterized by increased macrophage phagocytosis.</p>
    <p>Related art also exists that teaches that a hot water extraction of the crude plant parts of Uncaria and the subsequent dialysis of the solubilized products yields a composition which has a high degree of the immune stimulatory activities (U.S. Pat. Nos. 6039949, 6238675, 6361805). These activities were confirmed through increased lymphocyte phagocytosis and cytokine production and more recently, increased vaccine response. However, while increased leukocyte phagocytosis and cytokine production are characteristics of the immune response, they contribute to tissue injury during states of inflammation. Thus, current therapeutic approaches in treating inflammatory disorders usually seek to lower cytokine levels and inhibit leukocyte activity.</p>
    <heading>SUMMARY OF THE INVENTION</heading> <p>Aspects of the invention are summarized below to aid in the understanding of embodiment(s) of the invention and the application. Yet, the invention is fully defined by the claims of the application.</p>
    <p>In contrast to its immunostimulating alkaloids, preparations or decoctions of Uncaria plant material also exhibit an inherent immunosuppressive and anti-inflammatory result. This dichotomy between the immunostimulatory (pro-inflammatory) alkaloids and the immunosuppressive (anti-inflammatory) agents, concurrent yet opposing actions—stimulation and suppression—limit the true potential and benefits of either component. Thus, a method of distinguishing and removing from Uncaria decoctions the immunostimulatory alkaloids would result in an Uncaria extract with enhanced efficacy and therapeutic potential of the polar, immunosuppressive, TNF-alpha inhibiting agents. The present invention describes an extract and method for extracting or depleting from plants of the Uncaria species (Cat's Claw or Uño de gato) it's lipophilic, immunostimulating alkaloids whilst retaining and then further concentrating its polar, immunosuppressive agents. The process generally comprises an organic extraction(s) and drying of decocting crude Uncaria plant parts. The resulting Uncaria extract is substantially deplete of immunostimulatory actives and retains enhanced anti-inflammatory components and antioxidant capacities.</p>
    <p>The Uncaria extract described herein demonstrates antioxidant activity and also an ability to inhibit the formation of inflammatory and immune mediators like tumor necrosis factor alpha (TNFalpha) by suppressing the activation of genes associated with inflammation and the immune response. This transcriptional inhibition likely results from suppression of nuclear factor kappa B (NF-kB) and functions to suppress an over active immune response that contributes to tissue injury during states of inflammation. It is counterintuitive that the enhancement and concentration of known immunostimulatory (i.e. pro-inflammatory) alkaloids would act as immunosuppressants and exert any anti-inflammatory activity.</p>
    <p>This invention demonstrates that the Uncaria extract by the process disclosed herein is characterized by enhanced immunosuppressant and anti-inflammatory action and therefore requires an effective dose twenty times less (i.e. 2 mg/kg) than extracts or decoctions produced by other methods. Anti-inflammatory and transcriptionally acting immune modulating actions of the Uncaria extract preparations described herein have application in disorders characterized by NF-kB activation, oxidant burden, enhanced cytokine production and cell death. These disorders include, but are not limited to, arthritis (both osteoarthritis and rheumatoid), inflammatory bowel disease (IBD), gastritis, chronic inflammation of the eyes, skin, liver, muscles and kidney, fibromyalgia, atherosclerosis, and Alzheimer's disease.</p>
    <heading>BRIEF DESCRIPTION OF THE FIGURES</heading> <p>FIG. 1. A comparison of Uncaria parent and extract by high performance liquid chromatography (HPLC). As shown in the overlaid chromatograms, the Uncaria extract derived from the methods described herein (Vincaria™) is substantially deplete of the immunostimulating alkaloids found in the parent (Uncaria spp) whilst retaining and thus enhancing the efficacy and therapeutic potential of the polar, immunosuppressive and TNF-alpha inhibiting (ant-inflammatory) components.</p>
    <heading>DESCRIPTIONS OF EMBODIMENTS</heading> <p>The Uncaria extract(s) prepared by the processed disclosed herein result in a composition that is low in alkaloid content. The descriptions are exemplary methods for the purpose of resolving the extract. An ordinarily skilled practitioner could conceive of variations of the methods in light of the disclosure and the results to be achieved.</p>
    <heading>Extraction Process 1</heading> <p>An aqueous extract of the Uncaria species is achieved by a decoction method as previously described. A preferred decoction comprises a quantity of raw or dried botanical in hot water. More specifically, solid matter of the plant material such as roots, bark and or powders of genus Uncaria are mixed in such a ratio with water that when heated for a period of time at a temperature of approximately 90-100 degrees centigrade, with or without agitation, to yield a brown aqueous extract also known as a decoction or tea. The decoction or tea is then filtered of all solid matter for further processing according to one aspect of the invention. The filtrate is subsequently dried to remove all aqueous components. Acceptable drying methods include air-drying, evaporation, or vacuum drying or an equivalent.</p>
    <p>An organic solvent Is subsequently added to the dried decoction or extract. A preferred organic solvent is chloroform/methanol (2:1) added in a volume-to-volume ratio of 1:1 to 1:20. Another suitable organic solvent is ethyl acetate. The dried decoction and organic solvent are mixed and subsequently separated. One preferred manner of separating the polar constituents and alkaloids of the dried decoction involves exposure of the dried decoction to organic solvent. One convenient means of exposure comprises placement of the dried concoction into a sack or bag, constructed of paper cotton or other equivalent materials, and immersion in organic solvent. Following exposure, the bag is subsequently removed from the organic solvent and dried to eliminate any residual organic solvent. Drying resolves the genus Uncaria extract comprised of polar constituents and largely deplete of the alkaloids captured by the organic solvent. Drying and may be accomplished by one or more drying processes including heating, air drying, freeze drying or vacuum drying. Depletion of alkaloids content is confirmed by high performance liquid chromatography (HPLC) as indicated in FIG. <b>1</b>.</p>
    <heading>Extraction Process 2</heading> <p>An aqueous extract of the Uncaria species is achieved by a decoction method as previously described. To this extract in its liquid phase the organic solvent ethyl acetate, is added. Following agitation and settling the organic layer is separated from the aqueous and the organic layer discarded. The solutes remaining in the aqueous layer are the resolved by drying. Several drying processes can be used: heating, air-drying, freeze-drying, or vacuum drying. Depletion of alkaloids content is confirmed by high performance liquid chromatography (HPLC) as indicated in FIG. <b>1</b>.</p>
    <heading>Extraction Process 3</heading> <p>This process employs the same decoction extraction method as described for Examples 1 and 2, but before the extraction of organic material is employed; the solute in the decoction is isolated by drying. To this dried powder the organic solvents are added (chloroform/methanol, 2:1: or ethyl acetate). This mixture is agitated for adequate mixing, followed by settling. The liquid organic solvent is removed and discarded, and the solutes are dried again as outlined by similar methods employed for drying in Example 1 or 2. Depletion of alkaloids content is confirmed by high performance liquid chromatography (HPLC) as indicated in FIG. <b>1</b>.</p>
    <p>Table 1: Antioxidant and anti-TNFalpha actions of cat's claw formulations. Note that in order to assess activity in micropulverized Uncaria, a hot water extraction was performed and this decoction used for evaluation. TNFapha production was assessed in cultured macrophages (RAW 264.7 cells) stimulated with bacterial endotoxin (LPS: 0.5 μg/mL). After one hour exposure to LPS, media was collected and TNFalpha levels measured by ELISA. DPPH scavenging was spectophometerically measured by a reduction in absorbance at 515 nm. Results are depicted as IC<sub>50</sub>, which is the concentration that produces a 50% inhibition. A lower IC<sub>50 </sub>value is indicative of greater potency. Note: For each assay, potency was significantly greater in alkaloid depleted freeze-dried formulation when compared to the other formations (P&lt;0.01)</p>
    <p>
      <tables> <table frame="none" colsep="0" rowsep="0" class="description-table"> <tgroup align="left" colsep="0" rowsep="0" cols="4"> <colspec colname="1" colwidth="49pt" align="center"> </colspec> <colspec colname="2" colwidth="56pt" align="center"> </colspec> <colspec colname="3" colwidth="56pt" align="center"> </colspec> <colspec colname="4" colwidth="56pt" align="center"> </colspec> <thead> <tr class="description-tr"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td" colspan="4"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Freeze-dried</td>
                <td class="description-td"> </td>
                <td class="description-td"> </td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Alkaloid Deplete</td>
                <td class="description-td">Freeze-dried</td>
                <td class="description-td">Micropulverized</td>
              </tr> <tr class="description-tr"> <td class="description-td"> </td>
                <td class="description-td">Uncaria</td>
                <td class="description-td">Uncaria Alkaloid</td>
                <td class="description-td">Uncaria</td>
              </tr> <tr class="description-tr"> <td class="description-td">Assay IC<sub>50</sub> </td>
                <td class="description-td">(Vincaria ™)</td>
                <td class="description-td">Intact</td>
                <td class="description-td">Alkaloid Intact</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td" colspan="4"> </td>
              </tr> </thead> <tbody valign="top"> <tr class="description-tr"> <td class="description-td">DPPH</td>
                <td class="description-td">12.6 μg/mL</td>
                <td class="description-td">20.8 μg/mL</td>
                <td class="description-td">150 μg/mL</td>
              </tr> <tr class="description-tr"> <td class="description-td">Anti-</td>
                <td class="description-td"> 9.5 ng/mL</td>
                <td class="description-td">14.1 ng/mL</td>
                <td class="description-td"> 28 ng/mL</td>
              </tr> <tr class="description-tr"> <td class="description-td">TNFalpha</td>
              </tr> <tr class="description-tr"> <td namest="1" nameend="4" align="center" rowsep="1" class="description-td" colspan="4"> </td>
              </tr> </tbody> </tgroup> </table> </tables> </p>
    <heading>Antioxidant Activity</heading> <p>The extract processed according to the invention and produced from freeze-dried Uncaria plant matter a composition with enhanced antioxidant activity or ability to scavenge the stable free radical 2,2′-dipyridyl-2-pyridylhydrazone (DPPH) as compared to those preparations made from the manual manipulation of the bark, root or leaves to produce particulate powders. As demonstrated in Table 1, it has a lower 50% effective concentration (IC50) for scavenging DPPH radicals than compared powdered formulations.</p>
    <heading>Inhibition of TNFα Formation</heading> <p>The extract processed according to the invention and produced a composition with an enhanced ability to inhibit the formation of tumor necrosis factor alpha (TNFα) by macrophages stimulated by bacterial endotoxin [lipopolysaccharide (LPS)]. This activity is superior to the compared powdered formulations as well as freeze-dried preparations containing higher alkaloid content (Table 1). This supports the indication that the alkaloid constituents of the Uncaria species are not the components responsible for its immunosuppressive activity but rather suggest their role in the enhancement of the immune system.</p>
    <heading>Alkaloid Depletion</heading> <p>Uncaria derived alkaloids (both pentacyclic and oxindole) have been suggested as the constituents responsible for its immuno-enhancing activity. However, in the treatment of inflammatory disease, the enhancement of the immune response is counter-productive while the suppression of an overactive immune system is the more common and logical approach to therapy and a target for therapeutic innovations. Thus, for enhanced anti-inflammatory actions, it is necessary to deplete effective Uncaria formulations of these alkaloids.</p>
    <p>The extraction method herein described entails the concentration of Uncaria's active components by decoction and then the depletion of the alkaloid content through chemical manipulation with organic solvents. More particularly, the Uncaria extract is significantly deplete of oxindole, pentacyclic and tetracyclic alkaloid when compared to the parent botanical. These alkaloids are more lipophilic than the active antioxidant and NF-κB suppressive components. Thus, treatment of a decoction of Uncaria plant material with an organic solvent to resolve the aqueous (i.e. non-organic components) significantly reduces the alkaloid content whilst retaining the polar anti-inflammatory compounds. As clearly shown in Table 1, specific alkaloids used as markers to quantify the resultant composition's alkaloid content demonstrate 35-fold depletion with an associated improvement in antioxidant and anti-TNFα action.</p>
    <p>Laboratory results indicate that the oxindole alkaloid content of the Uncaria extract processed as described herein is less than 0.3 mg/g of dired decoction. Decoctions are generally 20% of the parent Uncaria plant material. Thus, the non-alkaloid components are 5 times concentrated, or approximately 0.06 mg/g of raw botanical. Normal or starting detected values of oxidole alkaloid content are 9 mg/g of decoction or 1.8 mg/g of raw botanical. The extraction procedure reflects a depletion of at least 30 fold resulting in an almost undetectable quantity of oxidole alkaloids.</p>
    <p>A pharmaceutical dosage comprising a biologically active amount of the Uncaria extract produced as taught herein is contemplated for use singularly or in combination with other ingredients for human and animal use. Moreover particularly, a pharmaceutical dosage comprising a biologically active amount of the Uncaria extract can be embodied in suppositories, oral, topical, injectable or inhalable formats.</p>
    <p>The pharmaceutical dosage comprising a biologically active amount of the Uncaria extract is administered in a quantity sufficient to ameliorate conditions characterized by NF-κB activation, oxidant burden, enhanced cytokine production and cell death. The conditions are contemplated to include, but are not limited to, arthritis (both osteoarthritis and rheumatoid), inflammatory bowel disease (IBD), gastritis, chronic inflammation of the eyes, skin, liver, muscles and kidney, fibromyalgia, atherosclerosis, and Alzheimer's disease.</p>
    <p>While the invention has been described with reference to specific preferred embodiments and uses, it is certainly not limited to those precise embodiments or uses. Rather, many modifications, variations and applications will become apparent to persons skilled in the art without departure from the scope and spirit of the invention, as defined in the appended claims.</p>
    </div></div></div><div class="patent-section patent-tabular-section"><a id="backward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Cited Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4844901">US4844901</a></td><td class="patent-data-table-td patent-date-value">May 16, 1988</td><td class="patent-data-table-td patent-date-value">Jul 4, 1989</td><td class="patent-data-table-td ">Klaus Keplinger</td><td class="patent-data-table-td ">Oxindole alkaloids having properties stimulating the immunologic system</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US4940725">US4940725</a></td><td class="patent-data-table-td patent-date-value">Apr 3, 1989</td><td class="patent-data-table-td patent-date-value">Jul 10, 1990</td><td class="patent-data-table-td ">Klaus Keplinger</td><td class="patent-data-table-td ">Oxindole alkaloids having properties stimulating the immunologic system and preparation containing the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5302611">US5302611</a></td><td class="patent-data-table-td patent-date-value">Sep 30, 1992</td><td class="patent-data-table-td patent-date-value">Apr 12, 1994</td><td class="patent-data-table-td ">Klaus Keplinger</td><td class="patent-data-table-td ">Oxindole alkaloids having properties stimulating the immunologic system &amp; preparation containing the same</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US5723625">US5723625</a></td><td class="patent-data-table-td patent-date-value">Oct 4, 1996</td><td class="patent-data-table-td patent-date-value">Mar 3, 1998</td><td class="patent-data-table-td ">Immodal Pharmaka Gesellschaft M.B.H</td><td class="patent-data-table-td ">Process for the production of specific isomer mixtures from oxindole alkaloids</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6039949">US6039949</a></td><td class="patent-data-table-td patent-date-value">Feb 27, 1997</td><td class="patent-data-table-td patent-date-value">Mar 21, 2000</td><td class="patent-data-table-td ">Campamed, Inc.</td><td class="patent-data-table-td ">Plant extracts obtained by filtration, centrifuging and dialysis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6238675">US6238675</a></td><td class="patent-data-table-td patent-date-value">Nov 16, 1999</td><td class="patent-data-table-td patent-date-value">May 29, 2001</td><td class="patent-data-table-td ">Campamed Corp.</td><td class="patent-data-table-td ">Administering mammals</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6264994">US6264994</a><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td patent-date-value">Dec 8, 1998</td><td class="patent-data-table-td patent-date-value">Jul 24, 2001</td><td class="patent-data-table-td ">University Of Washington</td><td class="patent-data-table-td ">Compositions for treating alzheimer&#39;s disease and other amyloidoses</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US6361805">US6361805</a></td><td class="patent-data-table-td patent-date-value">Apr 2, 2001</td><td class="patent-data-table-td patent-date-value">Mar 26, 2002</td><td class="patent-data-table-td ">Ronald W. Pero</td><td class="patent-data-table-td ">Method of preparation and composition of a water soluble extract of the plant species uncaria for enhancing immune, anti-inflammatory, anti-tumor and DNA repair processes of warm blooded animals</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="npl-citations"></a><div class="patent-section-header"><span class="patent-section-title">Non-Patent Citations</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th colspan="3"class="patent-data-table-th">Reference</th></tr></thead><tr><td class="patent-data-table-td ">1</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G Konwalinka, Capillary electrophoretic analysis of oxidole alkaloids from Uncaria tomentosa, J of Chromatography, 609 (1992) pp 375-380, U.S.</td></tr><tr><td class="patent-data-table-td ">2</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">G. Laus et al., Separation of Stereoisomeric oxidole alkaloids from Uncaria tomentosa by high performance liquid chromatography, J Chromatography, A, 662 (1994) U.S.</td></tr><tr><td class="patent-data-table-td ">3</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">H Stuppner et al, HPLC Analysis of the Main Oxidole Alkaloids from Uncaria tomentosa, Chromatography, V 34, No 11/12, Dec. 1992, U.S.</td></tr><tr><td class="patent-data-table-td ">4</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">J Piscoya et al., Efficacy and safety of freeze-dried cat's claw in osteorarthritis of the knee: mechanisms . . . , Inflamm.res.50(2001) 442-448, U.S.</td></tr><tr><td class="patent-data-table-td ">5</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">K Keplinger et al, Uncaria tomentosa (Willd.) DC.-Ethnomedicinal use and new pharmacological, toxicological and botanical results, J Ethnopharmacology 64 (1999) 23-34 U.S.</td></tr><tr><td class="patent-data-table-td ">6</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M Sandoval et al., Cat's Claw Inhibits TNalpha Prod. and Scavenges Free Radicals: Role in Cytoprotection, Free Radical Biology &amp; Med, vol. 29 No. 1 pp 71-78,2000, U.S.</td></tr><tr><td class="patent-data-table-td ">7</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M Sandoval-Chacon, Antiinflammatory actions of cat's claw: the role of NF-kappaB, Aliment Pharmacol Ther 1998;12;1279-1289 U.S.</td></tr><tr><td class="patent-data-table-td ">8</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M Sandoval-Chacon, Antiinflammatory actions of cat's claw: the role of NF-κB, Aliment Pharmacol Ther 1998;12;1279-1289 U.S.</td></tr><tr><td class="patent-data-table-td ">9</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">M. Sandoval et al., Anti-inflammatory and antioxidant activities of cat's claw (Uncaria tomentosa and Uncaria guianensis) are indept . . . , Phytomedicine 9:325-337, 2002, U.S.</td></tr><tr><td class="patent-data-table-td ">10</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Mark JS Miller et al., Dietary antioxidants protect gut epithelial cells from oxidant-induced apoptosis, BMC Comp and Alternative Med Dec. 2001, I:II, U.S.</td></tr><tr><td class="patent-data-table-td ">11</td><td class="patent-data-table-td "><span class='patent-tooltip-anchor' data-tooltip-text="Cited by examiner"> *</span></td><td class="patent-data-table-td ">Medical Botany, Lewis et al., published 1977 by John Wiley &amp; Sons (NY), pp 277-279 and 509.*</td></tr><tr><td class="patent-data-table-td ">12</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">R Aquino et al, New quinovic acid glycosides from Uncaria Tomentosa, J Natural Prod, vol. 51, No. 2, pp 257-261, Mar.-Apr. 1998, U.S.</td></tr><tr><td class="patent-data-table-td ">13</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">S Lamm, Persistant response to pneumococcal vaccine in individuals supplemented with a novel water soluable extract of Uncaria tomentosa, C-MED-100(R) Phytomedicine, vol. 8(4) pp. 267-274 U.S., no date provided.</td></tr><tr><td class="patent-data-table-td ">14</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">S Lamm, Persistant response to pneumococcal vaccine in individuals supplemented with a novel water soluable extract of Uncaria tomentosa, C-MED-100® Phytomedicine, vol. 8(4) pp. 267-274 U.S., no date provided.</td></tr><tr><td class="patent-data-table-td ">15</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Y Sheng et al, Enhanced DNA repair, immune function and reduced toxicity of C-MED-100, a novel aqueous extract from Uncaria tomentosa, J Ethnopharmacology 69 (2000) 115-126 US.</td></tr><tr><td class="patent-data-table-td ">16</td><td class="patent-data-table-td "></td><td class="patent-data-table-td ">Y Sheng et al, Induction of Apoptosis and Inhibition of Proliferation of Human Tumor Cells Treated with Extracts of Uncaria Tomentosa, Anticancer Research 18:3363-3368 (1998).</td></tr></table><div class="patent-section-footer">* Cited by examiner</div></div><div class="patent-section patent-tabular-section"><a id="forward-citations"></a><div class="patent-section-header"><span class="patent-section-title">Referenced by</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Citing Patent</th><th class="patent-data-table-th">Filing date</th><th class="patent-data-table-th">Publication date</th><th class="patent-data-table-th">Applicant</th><th class="patent-data-table-th">Title</th></tr></thead><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7611732">US7611732</a></td><td class="patent-data-table-td patent-date-value">Jul 26, 2004</td><td class="patent-data-table-td patent-date-value">Nov 3, 2009</td><td class="patent-data-table-td ">Michael Bentley</td><td class="patent-data-table-td ">Nutritional supplement for osteoarthritis</td></tr><tr><td class="patent-data-table-td citation-patent"><a href="/patents/US7910136">US7910136</a></td><td class="patent-data-table-td patent-date-value">Aug 7, 2008</td><td class="patent-data-table-td patent-date-value">Mar 22, 2011</td><td class="patent-data-table-td ">Sierra Mountain Minerals, Inc.</td><td class="patent-data-table-td ">Nutritional supplement for osteoarthritis</td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="classifications"></a><div class="patent-section-header"><span class="patent-section-title">Classifications</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th"> </th><th class="patent-data-table-th"> </th></tr></thead><tr><td class="patent-data-table-td ">U.S. Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://www.uspto.gov/web/patents/classification/uspc424/defs424.htm&usg=AFQjCNH9_TEmt6LWxUKihruum311Bzz0Rg#C424S725000">424/725</a></span></td></tr><tr><td class="patent-data-table-td ">International Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=C11B0001100000">C11B1/10</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://web2.wipo.int/ipcpub/&usg=AFQjCNER44F5jlVoswCkvW3YEcB5lW4moA#refresh=page&notion=scheme&version=20130101&symbol=A61K0036740000">A61K36/74</a></span></td></tr><tr><td class="patent-data-table-td ">Cooperative Classification</td><td class="patent-data-table-td "><span class="nested-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=A61K36/74">A61K36/74</a></span>, <span class="nested-value"><a href="http://www.google.com/url?id=gLRoBAABERAJ&q=http://worldwide.espacenet.com/classification&usg=AFQjCNGs5WqSrPE3A4ZP63zGuM6PRNfEFA#!/CPC=C11B1/10">C11B1/10</a></span></td></tr><tr><td class="patent-data-table-td ">European Classification</td><td class="patent-data-table-td "><span class="nested-value">C11B1/10</span>, <span class="nested-value">A61K36/74</span></td></tr></table><div class="patent-section-footer"></div></div><div class="patent-section patent-tabular-section"><a id="legal-events"></a><div class="patent-section-header"><span class="patent-section-title">Legal Events</span></div><table class="patent-data-table"><thead class="patent-data-table-thead"><tr class="patent-data-table"><th class="patent-data-table-th">Date</th><th class="patent-data-table-th">Code</th><th class="patent-data-table-th">Event</th><th class="patent-data-table-th">Description</th></tr></thead><tr><td class="patent-data-table-td patent-date-value">Mar 7, 2012</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">8</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Oct 26, 2010</td><td class="patent-data-table-td ">B1</td><td class="patent-data-table-td ">Reexamination certificate first reexamination</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">CLAIMS 1-14 ARE CANCELLED. NEW CLAIMS 15-18 ARE ADDED AND DETERMINED TO BE PATENTABLE.</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Sep 28, 2010</td><td class="patent-data-table-td ">ERR</td><td class="patent-data-table-td ">Erratum</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">&quot;ALL REFERENCE TO REEXAMINATION CERTIFICATE NO. C1 6797286 TO BOBROWSKI OF SCOTTSDALE, AZ FOR METHODS AND PREPARATIONS OF EXTRACTS OF UNCARIA SPECIES WITH REDUCED ALKALOID CONTENT APPEARING IN THE OFFICIAL OF 20090106 SHOULD BE DELETED, SINCE THE REEXAMINATION CERTIFICATE HAS BEEN VACATED.&quot;</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jan 6, 2009</td><td class="patent-data-table-td ">FPB1</td><td class="patent-data-table-td ">Expired due to reexamination which canceled all claims</td><td class="patent-data-table-td "></td></tr><tr><td class="patent-data-table-td patent-date-value">Dec 3, 2007</td><td class="patent-data-table-td ">FPAY</td><td class="patent-data-table-td ">Fee payment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Year of fee payment: </span><span class="nested-value">4</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">May 10, 2005</td><td class="patent-data-table-td ">RR</td><td class="patent-data-table-td ">Request for reexamination filed</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20050317</span></div></td></tr><tr><td class="patent-data-table-td patent-date-value">Jul 14, 2004</td><td class="patent-data-table-td ">AS</td><td class="patent-data-table-td ">Assignment</td><td class="patent-data-table-td "><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">RAINFOREST NUTRITIONALS, INC., ARIZONA</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOBROWSKI, PAUL J.;REEL/FRAME:014847/0632</span></div><div class="nested-key-value"><span class="nested-key">Effective date: </span><span class="nested-value">20030923</span></div><div class="nested-key-value"><span class="nested-key">Owner name: </span><span class="nested-value">RAINFOREST NUTRITIONALS, INC. 4727 E. BELL RD PMB</span></div><div class="nested-key-value"><span class="nested-key">Free format text: </span><span class="nested-value">ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:BOBROWSKI, PAUL J. /AR;REEL/FRAME:014847/0632</span></div></td></tr></table><div class="patent-section-footer"></div></div><div class="modal-dialog" id="patent-images-lightbox"><div class="patent-lightbox-controls"><div class="patent-lightbox-rotate-controls"><div class="patent-lightbox-rotation-text">Rotate</div><div class="rotate-icon rotate-ccw-icon"></div><div class="rotate-icon rotate-cw-icon"></div></div><div class="patent-lightbox-index-counter"></div><a class="patent-lightbox-fullsize-link" target="_blank">Original Image</a><div class="patent-drawings-control patent-drawings-next"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_right.png" alt="Next page"width="21" height="21" /></div><div class="patent-drawings-control patent-drawings-prev"><img class="patent-drawings-button-img"src="/googlebooks/images/kennedy/page_left.png" alt="Previous page"width="21" height="21" /></div></div><div class="modal-dialog-content"><div class="patent-lightbox-image-holder"><div class="patent-lightbox-placeholder"></div></div></div></div><script>_OC_initPatentsAtb({image_not_available_html: " Image not available"});</script></div></div></div></td></tr></table><script>(function() {var href = window.location.href;if (href.indexOf('?') !== -1) {var parameters = href.split('?')[1].split('&');for (var i = 0; i < parameters.length; i++) {var param = parameters[i].split('=');if (param[0] == 'focus') {var elem = document.getElementById(param[1]);if (elem) {elem.focus();}}}}})();</script><script>_OC_addFlags({LockSrc:"/books/javascript/lock_8a2b04e7bf975d5171d8e4c0b6365c7a.js", Host:"http://www.google.com/", IsBooksRentalEnabled:1, IsWebstoreDisplayCaseEnabled:1, IsObfuscationEnabled:1, IsBrowsingHistoryEnabled:1, IsWebReaderSvgEnabled:0, IsGeoLayerEnabled:1, IsImageModeNotesEnabled:1, IsCopyMenuItemEnabled:1, IsGiftingEnabled:0, IsWebReaderUniversalPaginatorEnabled:0, IsOfflineBubbleEnabled:1, IsReaderEnabledForPlayRequests:1, IsFutureOnSaleVolumesEnabled:1, IsOfflineRestrictedCopyEnabled:1, IsBooksUnifiedLeftNavEnabled:1, IsRestrictedCopyEnabled:1, IsZipitFolderCollectionEnabled:1, IsEndOfSampleRecommendationsEnabled:1, IsRatingsOnBookcardsEnabled:1, IsAdsDisabled:0, IsIframePageDisplayEnabled:0, IsEmbeddedMediaEnabled:1, IsImageModeAnnotationsEnabled:1, IsMyLibraryGooglePlusEnabled:1, IsImagePageProviderEnabled:0, IsBookcardListPriceSmall:0, IsInternalUser:0, IsBooksShareButtonEnabled:0, IsPreOrdersEnabled:0, IsDisabledRandomBookshelves:0, WebstoreDisplayCasePosition:3});_OC_Run({"enable_p13n":false,"add_vol_to_collection_base_url":"http://www.google.com/patents?op=add\u0026sig=ACfU3U3xgxsTnPDAP9YvcLQst4zn0WfoBA\u0026id=gLRoBAABERAJ","remove_vol_from_collection_base_url":"http://www.google.com/patents?op=remove\u0026sig=ACfU3U06kyElzF-Pexgv1QGRhoEzUfRQFA\u0026id=gLRoBAABERAJ","logged_in":false,"p13n_save_user_settings_url":"http://www.google.com/patents?op=edit_user_settings\u0026sig=ACfU3U1c3TB6HoxfJQ5LeXYJMJoU7p2Qdw","is_cobrand":false,"sign_in_url":"https://www.google.com/accounts/Login?service=\u0026continue=http://www.google.com/patents%3Fhl%3Den\u0026hl=en","is_play_enabled":true}, {"volume_id":"","is_ebook":true,"volumeresult":{"has_flowing_text":false,"has_scanned_text":true,"can_download_pdf":false,"can_download_epub":false,"is_pdf_drm_enabled":false,"is_epub_drm_enabled":false,"download_pdf_url":"http://www.google.com/patents/download/Methods_and_preparations_of_extracts_of.pdf?id=gLRoBAABERAJ\u0026output=pdf\u0026sig=ACfU3U1MgRmF7duHOqWyWByGiBTNKNw9Vg"},"sample_url":"http://www.google.com/patents/reader?id=gLRoBAABERAJ\u0026printsec=frontcover\u0026output=reader\u0026source=gbs_atb_hover","is_browsable":true,"is_public_domain":true}, {});</script><div id="footer_table" style="font-size:83%;text-align:center;position:relative;top:20px;height:4.5em;margin-top:2em"><div style="margin-bottom:8px"><a href=http://www.google.com/><nobr>Google&nbsp;Home</nobr></a> - <a href=//www.google.com/patents/sitemap/><nobr>Sitemap</nobr></a> - <a href=http://www.google.com/googlebooks/uspto.html><nobr>USPTO Bulk Downloads</nobr></a> - <a href=/intl/en/privacy/><nobr>Privacy Policy</nobr></a> - <a href=/intl/en/policies/terms/><nobr>Terms of Service</nobr></a> - <a href=https://support.google.com/faqs/answer/2539193?hl=en><nobr>About Google Patents</nobr></a> - <a href="http://www.google.com/tools/feedback/intl/en/error.html" onclick="try{_OC_startFeedback({productId: '72792',locale: 'en'});return false;}catch(e){}"><nobr>Send Feedback</nobr></a></div><span>Data provided by IFI CLAIMS Patent Services</span><br><span >&copy;2012 Google</span></div> <script type="text/javascript">var gaJsHost = (("https:" == document.location.protocol) ? "https://ssl." : "http://www.");document.write(unescape("%3Cscript src='" + gaJsHost + "google-analytics.com/ga.js' type='text/javascript'%3E%3C/script%3E"));</script><script type="text/javascript">var pageTracker = _gat._getTracker("UA-27188110-1");pageTracker._setCookiePath("/patents/");pageTracker._trackPageview();</script> </body></html>